What You Should Know: - A consortium of 10 National Health Service Trusts — the publicly funded healthcare system in England — is now deploying the MONAI-based AIDE platform across four of its hospitals, providing artificial intelligence (AI)-enabled disease-detection tools to healthcare professionals serving 5 million patients a year. - AIDE, short for AI Deployment Engine, is expected to be rolled out next year across 11 NHS hospitals serving 18 million patients, bringing AI
Read More
Oatmeal Health Brings AI-Powered Lung Cancer Screening to The Clinic in Oklahoma
What You Should Know: - Central Oklahoma Family Medical Center FQHC (The Clinic) has selected Oatmeal Health, a veteran-owned Patient Success Service to bring tech-enabled lung cancer screenings to their patients. - As part of the partnership, Oatmeal Health will provide white-glove, concierge service, offering our support without FQHC’s shouldering the burden or cost. Tech-Enabled Lung Cancer Screening Currently, lung screening rates hover at around 4 percent
Read More
Research: Proscia AI Predicts Diagnostic Agreement for Melanoma
What You Should Know: - Proscia® a provider of digital and computational pathology solutions, has released study results on new artificial intelligence (AI) that predicts diagnostic agreement for melanoma, the deadliest form of skin cancer. - The findings, which were presented at the European Conference on Computer Vision (ECCV) 2022, highlight the potential of the technology to improve diagnostic accuracy for melanoma and other diseases with low pathologist concordance. Findings
Read More
How Actionable Data and Expert Analysis Supports Service Providers, Fosters Better Care and Ensures Financial Benefits
Approximately 42% of Medicare beneficiaries are enrolled in Medicare Advantage plans—a segment projected to reach 46% by 2025. Due to rapid growth of the 65-and-older portion of the population, Medicare expenditures are forecast to reach $1,559.4 billion in 2028, with spending per enrollee reaching $20,751. Key trends are influencing this growth, including: - An aging population - Continued increase in overall Medicare costs - Government support and benefit flexibility (e.g.,
Read More
Tribun Health, Mindpeak Partner on AI Diagnostic Tool for Breast Cancer for Pathologists
What You Should Know: - Tribun Health, the European leader in software development for digital pathology, is pleased to announce a strategic partnership with Mindpeak, a global leader for pathology artificial intelligence (AI) software with world-class industry experts in the development of AI algorithms to provide precision and speed in clinical pathology. - Together, Tribun Health and Mindpeak help pathologists analyze whole-slide-images (WSI) of immunohistochemically (IHC) stained human
Read More
How Medical Researchers Can Leverage Tech to Help Streamline Biospecimen Matchmaking and Procurement
Many medical advancements – from life-saving vaccines and treatments to new diagnostic tests like liquid biopsies – are built on research that involves human biospecimens. Biofluids, tissue and cells are indispensable resources for the medical researcher, yet the process of sourcing these biospecimens can be woefully frustrating and inefficient. These challenges can have a direct, negative impact on the pace of discovery, creating urgency for improved access to the biospecimens researchers need
Read More
3 Steps to Approach & Tackle Digital Transformation in Healthcare
Artificial intelligence (AI) is predicted to save the US healthcare economy $150 billion by 2026. Replacing legacy systems and changing standard operating procedures, hospitals are moving to capitalize on technology and the ways it can change a historically hesitant to change sector. The big question is how fast teams are going to implement changes. Healthcare leadership recently reported that their organizations are 60% through their digitalization journey. IT leaders must be leading
Read More
Potential of Implementing Polygenic Risk Scores in Healthcare Systems
The promise of personalized medicine is a world in which interventions, screening, and therapeutics are targeted to those most likely to get the disease. Polygenic risk scores will help society reach this ambition by accurately assessing the contribution that one’s DNA makes to disease risk. When Thomas Jefferson wrote in the Declaration of Independence that ‘all men are created equal,’ he captured the essential concept of equality on which the US Constitution is based. Although no one would
Read More
Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration
Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers, so they can
Read More
To Engage and Activate Patients, CRM Alone Isn’t Enough
We talk about patient engagement a lot in healthcare today. But the reality is, we often don’t just want a patient to engage with a piece of content or information; we want them to take action. The traditional CRM and marketing automation are great tools for the former – keeping patients and their healthcare providers connected. But it does little to move beyond a digital connection. Today’s patients (or, consumers) expect more from all of their relationships, especially their healthcare
Read More
